core peptides semaglutide price Review 2026 — Pricing, COAs & Finnrick Rating Semaglutide GLP-1 Receptor Agonist Research

The rise in GLP-1 adoption will put further pressure on CPG brands to adjust global portfolios to meet the shifting taste, functional health & dietary preferences

With increased utilization there have been concerns about potential risks

Beauty buffs on a mission to lose a few pounds fast are showing up with Ozempic body but its not the svelte physique they were promised.

New Benefits Canada report reveals GLP-1 medications are a major driver of employer drug plan cost increases in 2026 despite expected generic approvals.

Very interesting paper just published in European Heart Journal Supplements by Arturo Cesaro, Vincenzo AcerboandPaolo Calabr

Middle age represents a critical window for metabolic and cognitive health, particularly in the context of rising obesity and diabetes rates